Relmada Therapeutics, Inc. RLMD Cash received from option exercises
Cash received from option exercises at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s cash received from option exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s cash received from option exercises?
- Relmada Therapeutics, Inc. (RLMD) reported cash received from option exercises of $160M in Q1 2026.
- What does cash received from option exercises mean?
- Cash inflows resulting from employees or other stakeholders exercising their vested stock options to purchase company shares. This metric reflects the value realized by participants and provides a source of non-dilutive capital for the firm.